Abstract
Despite overall improvements in cardiovascular mortality, young women who experience ischemic heart disease (IHD) continue to have high mortality rates. Furthermore, young women often do not benefit from IHD primary prevention initiatives because they are younger than the age at which risk factor screening typically commences. Unique to women may be a predisposition to early onset of IHD because of endocrine and metabolic conditions such as polycystic ovary syndrome (PCOS). PCOS typically consists of menstrual irregularities, subfertility, and hyperandrogenism and affects 7-18% of women of reproductive age.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
